Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SM08502 |
Synonyms | |
Therapy Description |
SM08502 is a small molecule inhibitor of Wnt signaling, through CDC-like kinase (CLK), that may regulate cell proliferation (PMID: 31560935). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SM08502 | SM-08502|SM 08502 | WNT Inhibitor 16 | SM08502 is a small molecule inhibitor of Wnt signaling, through CDC-like kinase (CLK), that may regulate cell proliferation (PMID: 31560935). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03355066 | Phase I | SM08502 | A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors | Terminated | USA | 0 |